Kura Oncology Ownership | Who Owns Kura Oncology?


OverviewForecastRevenueFinancialsChartTranscripts

Kura Oncology Ownership Summary


Kura Oncology is owned by 93.79% institutional investors, 1.15% insiders, and 5.07% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.81% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.10% of its assets in Kura Oncology shares.

KURA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKura Oncology93.79%1.15%5.07%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.47M10.81%$54.64M
Suvretta capital management8.12M9.27%$46.83M
Bvf inc/il7.75M8.85%$44.74M
Blackrock6.97M8.30%$143.43M
Armistice capital6.20M7.08%$35.77M
Vanguard group4.82M5.54%$41.97M
Ecor1 capital3.56M4.09%$30.98M
Prosight management, lp3.18M3.63%$18.36M
State street2.88M3.44%$59.39M
Millennium management2.37M2.72%$20.62M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prosight management, lp3.18M4.48%$18.36M
Alethea capital management558.44K4.16%$4.86M
Foresite capital management iv816.88K3.81%$4.71M
Bvf inc/il7.75M1.60%$44.74M
Suvretta capital management8.12M1.41%$46.83M
Sectoral asset management323.57K1.23%$1.87M
Ecor1 capital3.56M1.17%$30.98M
1492 capital management423.95K1.13%$2.45M
Boxer capital1.00M1.08%$20.59M
Artal group1.82M0.96%$37.47M

Top Buyers

HolderShares% AssetsChange
Millennium management2.37M0.01%1.52M
Blackrock funding, inc. /de9.47M0.00%1.29M
Prosight management, lp3.18M4.48%1.10M
Qube research1.91M0.01%738.76K
D. e. shaw1.15M0.01%727.99K

Top Sellers

HolderShares% AssetsChange
Deerfield management company, l.p. (series c)---5.41M
Paradigm biocapital advisors lp---4.33M
Ra capital management---4.00M
Avoro capital advisors---2.25M
Ecor1 capital3.56M1.17%-2.25M

New Positions

HolderShares% AssetsChangeValue
Sectoral asset management323.57K1.23%323.57K$1.87M
Apis capital advisors180.00K0.37%180.00K$1.04M
Gsa capital partners llp89.31K0.06%89.31K$778.00K
Los angeles capital management77.96K0.00%77.96K$449.82K
Alps advisors46.66K0.00%46.66K$269.23K

Sold Out

HolderChange
National bank of canada /fi/-1.00
Ifp advisors-9.00
Quantbot technologies lp-14.00
Nelson, van denburg & campbell wealth management group-14.00
Smartleaf asset management-17.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025183-2.14%82,143,9175.53%931.18%11216.67%43-24.56%
Mar 31, 2025187-1.06%80,458,6251.94%921.12%97-19.83%5762.86%
Dec 31, 2024104-43.48%28,722,448-65.13%330.37%68-17.07%14-75.00%
Sep 30, 20241832.23%82,304,5292.31%941.03%82-2.38%56-9.68%
Jun 30, 20241794.68%80,450,005-0.33%951.04%84-11.58%6231.91%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.69M3.10%-59.74K
Vanguard US Total Market Shares ETF2.17M2.68%3.54K
iShares Russell 2000 ETF1.85M2.13%-35.07K
SPDR® S&P Biotech ETF1.27M1.47%31.46K
HBM Healthcare Investments AG Ord1.21M1.40%-
Vanguard Institutional Extnd Mkt Idx Tr974.31K1.12%-440.17K
Invesco MSCI World ETF897.58K1.03%897.58K
BlackRock Advantage Small Cap Core Instl769.61K0.89%125.68K
Fidelity Small Cap Index748.20K0.86%-11.97K
iShares Russell 2000 Value ETF699.17K0.81%17.81K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 08, 2025WILSON TROY EDWARD President & CEOBuy$410.14K
Aug 13, 2025WILSON TROY EDWARD President and CEOBuy$89.62K
Aug 12, 2025WILSON TROY EDWARD President and CEOBuy$213.58K
May 19, 2025Bair Teresa Brophy Chief Legal OfficerSell$9.29K
May 19, 2025FORD KATHLEEN Chief Operating OfficerSell$9.78K

Insider Transactions Trends


DateBuySell
2025 Q33-
2025 Q2-2
2025 Q1-15
2024 Q4-1
2024 Q3--

KURA Ownership FAQ


Who Owns Kura Oncology?

Kura Oncology shareholders are primarily institutional investors at 93.79%, followed by 1.15% insiders and 5.06% retail investors. The average institutional ownership in Kura Oncology's industry, Biotech Stocks , is 306.59%, which Kura Oncology falls below.

Who owns the most shares of Kura Oncology?

Kura Oncology’s largest shareholders are Blackrock funding, inc. /de (9.47M shares, 10.81%), Suvretta capital management (8.12M shares, 9.27%), and Bvf inc/il (7.75M shares, 8.85%). Together, they hold 28.93% of Kura Oncology’s total shares outstanding.

Does Blackrock own Kura Oncology?

Yes, BlackRock owns 8.30% of Kura Oncology, totaling 6.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 143.43M$. In the last quarter, BlackRock increased its holdings by 66.44K shares, a 0.96% change.

Who is Kura Oncology’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is Kura Oncology’s biggest shareholder by percentage of total assets invested, with 4.48% of its assets in 3.18M Kura Oncology shares, valued at 18.36M$.

Who is the top mutual fund holder of Kura Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kura Oncology shares, with 3.10% of its total shares outstanding invested in 2.69M Kura Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools